BrainStorm Cell Therapeutics Company
Brainstorm is a developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders.
Investors
.jpeg)
Technology:
Regenerative Medicine, Stem cell therapy
Industry:
Cell Therapy, Public
Headquarters:
New York, New York, United States
Founded Date:
2000-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
5
Total Funding:
51628019
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-04-03
Last Funding Type:
Grant
Register and Claim Ownership